ANDA 60666, held by Glaxosmithkline. Ampicillin/Ampicillin Trihydrate.
As of Nov 16, 2026, ANDA 60666 (Totacillin), held by Glaxosmithkline, was first approved by FDA on May 7, 1970, with 0 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| May 7, 1970 | Original application | Approved |
| TotacillinEQ 125MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
| TotacillinEQ 250MG BASE/5ML · for suspension;oral | Ampicillin/Ampicillin Trihydrate | Discontinued |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters